Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

This study (ROBO-CHIP) is testing whether robotic surgery combined with heated chemotherapy delivered directly into the abdomen (HIPEC) can effectively treat stomach cancer that has spread to the lining of the belly in a limited way. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with gastric (stomach) adenocarcinoma or certain types of esophageal-gastric junction cancer confirmed by biopsy - Your cancer has spread only within the abdominal lining (not to other distant organs) - Your general health and organ function (blood counts, kidney, liver, nutrition) meet the required levels - You are physically active enough to handle treatment (ECOG performance status 0–2) **You may NOT be eligible if...** - Your cancer has spread to organs outside the abdomen - Your blood counts, kidney, or liver function do not meet the required levels - You have poor nutritional status Talk to your doctor to see if this trial is right for you.